Close Menu

NEW YORK — AmoyDx said on Tuesday that it has partnered with Janssen Research and Development to develop a next-generation sequencing-based companion diagnostic for the Chinese market.

Under the terms of the deal, Xiamen, China-based AmoyDx will develop and secure Chinese regulatory approval for its LC10 Essential NGS panel as a companion diagnostic to an undisclosed cancer therapy.

Additional terms were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test.